Bipartisan Lifesaving AIDS Relief Plan At Risk Due to Pro-Life Opposition
PEPFAR also targets tuberculosis and malaria, and funding restrictions could allow these diseases to gain a foothold.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Dr. Dave Campbell, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news